Functional imaging of the suicidal brain

Nuclear Medicine Communications

Volumn 26, Issue 5, 2005, Pages 391-393

  Audenaert, Kurt ^a   Peremans, Kathelijne ^a   Goethals, Ingeborg ^a   Otte, Andreas ^a   Dierckx, Rudi ^a   van Heeringen, Cees ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CYSTEINE ETHYL ESTER TC 99M; ESCITALOPRAM; FLUORODEOXYGLUCOSE F 18; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR;

ANTISOCIAL BEHAVIOR; BORDERLINE STATE; DIAGNOSTIC IMAGING; EDITORIAL; HUMAN; NEUROTRANSMISSION; PERFUSION; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; SEROTONINERGIC SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUICIDE ATTEMPT; VERBAL BEHAVIOR;

ANIMALS; BEHAVIOR; BRAIN; BRAIN DISEASES; DEPRESSION; DEPRESSIVE DISORDER; HUMANS; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; RECEPTOR, SEROTONIN, 5-HT2A; SUICIDE; SUICIDE, ATTEMPTED;

EID: 18144380712     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200505000-00001     Document Type: Editorial

References (15)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. Washington DC: American Psychiatric Association; 2000.
2. Heeringen C, Audenaert K, Vervaet M, Dierckx R. Functional brain imaging in suicidal behaviour. In: Otte A, Audenaert K, Peremans K, Van Heeringen C, Dierckx R (editors): Nuclear Medicine in Psychiatry. Heidelberg: Springer; 2004.
3. Goethals I, Audenaert K, Jacobs F, Van den Eynde F, Bernagie K, Kolindou A, et al. Brain perfusion SPECT in impulsivity-related personality disorders. Behav Brain Research 2005; 157:187-192.
4. Soloff PH, Meltzer CC, Becker C, Greer PJ, Kelly TM, Constantine D. Impulsivity and prefrontal hypometabolism in borderline personality disorder. Psych Res Neuroimag 2003; 123:153-163.
5. Audenaert K, Goethals I, Van Laere K, Lahorte P, Brans B, Versijpt J, et al. SPECT neuropsychological activation procedure with the Verbal Fluency Test in attempted suicide patients. Nucl Med Commun 2002; 23:907-916.
6. Oquendo MA, Placidi GPA, Malone KM, Campbell C, Keilp J, Brodsky B, et al. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Arch Gen Psychiatr 2003; 60:14-22.
7. Tiihonen J, Kuikka JT, Bergstrom KA, Karhu J, Viinamaki H, Lehtonen J, et al. Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour. Eur J Nucl Med 1997; 24:1253-1260.
8. 1A receptor binding potential measured by PET using C-11 WAY-100635. Brain Res 2002; 954:173-182.
9. 2A receptor binding index in deliberate self-harm patients. Eur J Nucl Med 2001; 28:175-182.
10. Verkes RJ, Van der Mast RC, Hengeveld MW, Tuyl JP, Zwinderman AH, Van Kempen GMJ. Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression. Am J Psychiatr 1998; 155:543-547.
11. 2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors. Psychopharmacology 1997; 133:99-101.
12. 2A receptor density in impulsive, aggressive dogs with Tc-99m-ECD and I-123-5-I-R91150. Eur J Nucl Med Mol Imag 2003; 30:1538-1546.
13. 2A receptors in the impulsive aggressive dog measured with 123I-5-I R91150 SPECT. Eur J Nucl Med Mol Imag 2005; (in press).
14. Asberg M, Traskman L, Thoren P. 5-HIAA in cerebrospinal-fluid-biochemical suicide predictor. Arch Gen Psychiatr 1976; 33:1193-1197.
15. Williams J, Pollock L. Psychological aspects of the suicidal process. In: Van Heeringen C (editor): Understanding Suicidal Behaviour: the Suicidal Process Approach to Research, Treatment and Depression. Chicester: Wiley; 2001, pp. 76-94.